Discover industry trends early and align development, pricing and access strategies with payer needs globally

Balancing price-value and securing access is challenging in today’s environment. GPI delivers integrated insights, analytical solutions and strategy to make a measurable difference to commercial and access outcomes from early development through to post launch phase

Faster insights for better pricing decisions

From understanding the impact of international reference pricing to supporting local pricing insights, let our team lift the burden of frustrating data manipulation and analysis allowing you to focus on the strategy

One complete solution for informed price and access decisions

GPI’s one-stop solution is more cost-effective, faster and efficient than the traditional consultancy approach. Used across organizations by Pricing, Access, HEOR, Value, and Launch teams, to deliver a consistent approach to data-driven decision making from early development to product launch and expansion.

  • >1Mil

    rows of drug pricing data on our platform GPI pulse

  • >750K

    analogs in our database

  • 52

    passionate employees working globally

  • 12+

    diverse nationalities working at GPI

Experts in pricing

GPI leverages the latest technical thinking, advanced analytics and domain expertise to help our clients make the best price and acccess decisions.

Global Pricing Innovations offers biopharma pricing and access insights, analytics and specialist consulting

We offer novel solutions to address complex, industry-wide challenges and improve performance across price and access. Our insights platform is closely supported by the consultancy and service team

Richer insights through better data

Enrich insights, identify opportunities and make good decisions — all with data from GPI.

Comprehensive regulatory, pricing and market access and health technology outcome data. Track competitors, HTA insights or analyze analog’s journey and determine priorities, launch sequence tactics, price positioning, value-drivers and much more…

Power smarter decisions

When you have complete data for your launch, it’s easy to start formulating the right pricing strategy, with the right defensive message, at the right time.

Evaluate global decisions through HTA journeys and decisions, reimbursement restrictions and pricing outcomes. Understand key drivers and events behind price and reimbursement outcomes to help formulate the right strategy.

Reduce research time by 70%

Reduce research time and optimize internal resources by accessing a single source of consistent information in a ready to use format across teams. Instead of needing to engage with multiple agencies, GPI pulse provides a comprehensive source of information required to support a launch or evaluate commercial potential.

Industry expertise

Significant opportunities exist for biopharma companies. Successful companies will have robust operational, commercial and strategic alignment

Speciality medicines

Sustainable and accessible healthcare is a worldwide challenge. Companies must transform their pricing strategies to deliver cost-effective solutions that create sustainable medicine prices.


New product technology and innovation, alongside an evolving regulatory environment represent unprecedented opportunities for this sector. Companies need effective operations and price management to take advantage of these opportunities.

Hear what our clients think

GPI brings an extensive network of experts to support our international pricing needs. Their hard work and service are an invaluable attribute to our team.

Global Pricing Innovations is exactly the kind of company we were looking for. GPI provides us with best-in-class operational pricing and market access support to help grow our business.

GPI’s commitment to quality is outstanding. The group has a great geographic reach with an impressive understanding of pricing systems worldwide including connections to local market experts.

Highly knowledgeable team, faster, detailed and relevant responses compared to previous suppliers…

Indication specific data is more superior than currently available solutions, no one else is providing this level of granularity…